CYP 2.33% 21.0¢ cynata therapeutics limited

44c thank you, page-24

  1. 5,583 Posts.
    lightbulb Created with Sketch. 1
    Now you're being funny ash

    The University of owns the research conducted by its academic staff... it doesn't matter that newer research trumps old research conducted by a staff member who has an affiliation with a company in woop-woop.



    http://www.news-medical.net/news/20...and-scientific-founder-of-CDI-and-Cynata.aspx

    "Currently we are at pre-clinical stage.  The Cynata anticipates planning for a Phase 1 clinical trial to occur during late 2014. " Slukvin commenting on CYP's aspiration to initiate a trial.

    It's up to you who you want to trust ash... so do tell how is that trial coming along?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.